Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters

Country/Region as subject
Publication year range
1.
PLoS Pathog ; 13(9): e1006577, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28863187

ABSTRACT

Early events in the human airways determining whether exposure to Mycobacterium tuberculosis (Mtb) results in acquisition of infection are poorly understood. Epithelial cells are the dominant cell type in the lungs, but little is known about their role in tuberculosis. We hypothesised that human primary airway epithelial cells are part of the first line of defense against Mtb-infection and contribute to the protective host response in the human respiratory tract. We modelled these early airway-interactions with human primary bronchial epithelial cells (PBECs) and alveolar macrophages. By combining in vitro infection and transwell co-culture models with a global transcriptomic approach, we identified PBECs to be inert to direct Mtb-infection, yet to be potent responders within an Mtb-activated immune network, mediated by IL1ß and type I interferon (IFN). Activation of PBECs by Mtb-infected alveolar macrophages and monocytes increased expression of known and novel antimycobacterial peptides, defensins and S100-family members and epithelial-myeloid interactions further shaped the immunological environment during Mtb-infection by promoting neutrophil influx. This is the first in depth analysis of the primary epithelial response to infection and offers new insights into their emerging role in tuberculosis through complementing and amplifying responses to Mtb.


Subject(s)
Epithelial Cells/microbiology , Immunity, Innate , Lung/microbiology , Macrophages/immunology , Mycobacterium tuberculosis/immunology , Tuberculosis/immunology , Cells, Cultured , Humans , Interferon-gamma/immunology , Monocytes/immunology
3.
Methods ; 61(1): 52-62, 2013 May 15.
Article in English | MEDLINE | ID: mdl-23296020

ABSTRACT

Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical practice almost 10 years ago has revolutionised diagnosis of latent tuberculosis (TB) infection (LTBI). The commercially available IGRAs, TSPOT.TB (Oxford Immunotech, Oxford, UK) and QuantiFERON Gold In-Tube (Cellestis, Victoria, Australia), allow detection of TB infection with greater specificity and sensitivity than the tuberculin skin test (TST) and are now recommended for diagnosis of LTBI. The TSPOT.TB assay is a simplified enzyme-linked immunospot assay (ELISpot) that enumerates TB-specific T lymphocytes (T cells) secreting interferon-gamma (IFNγ). In comparison, the QuantiFERON Gold In-Tube assay constitutes an enzyme-linked immunosorbent assay (ELISA) to quantify IFNγ released into blood plasma after incubation of whole blood with TB antigens. Release of IFNγ, as a result of antigen stimulation of TB-specific T cells within blood, is indicative of TB infection. Although IGRAs have significant advantages over the TST in diagnosis of latent TB, they have significant limitations. Discovery of new antigens and advances in methodology for measuring cellular immunity have recently paved the way for novel tests that overcome these limitations. By establishing for the first time technological platforms for T cell based diagnosis in diagnostic service laboratories, IGRAs provide a bridgehead to clinical application of T cell based diagnosis in routine practice.


Subject(s)
Interferon-gamma Release Tests/standards , Interferon-gamma/blood , Latent Tuberculosis/diagnosis , Mycobacterium tuberculosis/isolation & purification , Tuberculosis, Pulmonary/diagnosis , Antigens, Bacterial/immunology , Enzyme-Linked Immunosorbent Assay , Enzyme-Linked Immunospot Assay , Humans , Interferon-gamma/metabolism , Interferon-gamma Release Tests/methods , Latent Tuberculosis/blood , Latent Tuberculosis/immunology , Latent Tuberculosis/microbiology , Mycobacterium tuberculosis/immunology , Sensitivity and Specificity , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , T-Lymphocytes/pathology , Tuberculin Test , Tuberculosis, Pulmonary/blood , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/microbiology
4.
Thorax ; 68(10): 955-61, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23976779

ABSTRACT

BACKGROUND: Patients undergoing tumour necrosis factor (TNF)-α antagonist therapy are at increased risk of latent tuberculosis infection (LTBI) reactivation. The aim of this study was to determine the optimum available screening strategy for identifying patients for tuberculosis (TB) chemoprophylaxis. METHODS: We conducted a prospective observational study of consecutive adults with chronic rheumatological disease referred for LTBI screening prior to commencement of TNF-α antagonist therapy. All patients included had calculation of TB risk according to age, ethnicity and year of UK entry, as described in the 2005 British Thoracic Society (BTS) guidelines and measurement of tuberculin skin test (TST) and T.Spot.TB. RESULTS: There were 187 patients included in the study, with 157 patients (84%) taking immunosuppressants. 137 patients would require further risk stratification according to the BTS algorithm, with 110 (80.3%) classified as being at low risk of having LTBI. There were 39 patients (35.5%) who were categorised as low risk but were either TST and/or T.Spot positive and would not have received chemoprophylaxis according to the BTS algorithm. Combination of all three methods (risk stratification and/or positive T.Spot and/or positive TST) identified 66 patients out of 137 who would potentially be offered chemoprophylaxis, which was greater than any single test or two-test combination. CONCLUSION: Performing both a TST and T.Spot in patients on immunosuppressants prior to commencement of TNF-α antagonist therapy gives an additional yield of potential LTBI compared with use of risk stratification tables alone. Our results suggest that use of all three screening modalities gives the highest yield of patients potentially requiring chemoprophylaxis.


Subject(s)
Immunosuppressive Agents/adverse effects , Latent Tuberculosis/diagnosis , Latent Tuberculosis/prevention & control , Mass Screening/methods , Rheumatic Diseases/drug therapy , Tuberculin Test/methods , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adult , Aged , Antitubercular Agents/therapeutic use , Chemoprevention , Chronic Disease , Female , Humans , Latent Tuberculosis/complications , Male , Middle Aged , Prospective Studies , Rheumatic Diseases/complications , Risk Assessment , United Kingdom
5.
Am J Respir Crit Care Med ; 185(6): 653-9, 2012 Mar 15.
Article in English | MEDLINE | ID: mdl-22198973

ABSTRACT

RATIONALE: The optimum strategy for monitoring liver function during antituberculous therapy is unclear. OBJECTIVES: To assess the value of the American Thoracic Society risk-factor approach for predicting drug-induced liver injury and to compare with a uniform policy of liver function testing in all patients at 2 weeks. METHODS: We conducted an observational study of adult patients undergoing therapy for active tuberculosis at a tertiary center. All patients had alanine transferase measurement at baseline and 2 weeks following commencement of therapy. Sensitivity, specificity, and positive and negative predictive values were used to assess strategies. MEASUREMENTS AND MAIN RESULTS: There were 288 patients included, and 21 (7.3%) developed drug-induced liver injury (57.1% "early" at 2 wk and 42.9% "late," after 2 wk). There were increased rates of individuals with HIV infection in the early drug-induced liver injury group compared with no drug-induced liver injury and late drug-induced liver injury groups (33% vs. 7.1% vs. 0%; P = 0.004). The American Thoracic Society algorithm had a sensitivity and specificity of 66.7 and 65.6%, respectively, for prediction of early and 22.2% and 63.7% for late drug-induced liver injury. The uniform monitoring policy had poor sensitivity but better specificity (22.2 and 82.1%) for prediction of late drug-induced liver injury. CONCLUSIONS: In our urban, ethnically diverse population, a risk-factor approach is neither sensitive nor specific for prediction of drug-induced liver injury. A uniform policy of liver function testing at 2 weeks is useful for prompt identification of a subgroup who develop early drug-induced liver injury and may offer better specificity in ruling out late drug-induced liver injury.


Subject(s)
Antitubercular Agents/therapeutic use , Chemical and Drug Induced Liver Injury/prevention & control , Liver Function Tests/standards , Monitoring, Physiologic/standards , Practice Guidelines as Topic , Tuberculosis/drug therapy , Adult , Alanine Transaminase/blood , Antitubercular Agents/adverse effects , Chemical and Drug Induced Liver Injury/metabolism , Female , Follow-Up Studies , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , ROC Curve , Risk Factors , Tuberculosis/metabolism
6.
Water Environ Res ; 94(10): e10781, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36195318

ABSTRACT

Organic water pollutants are ubiquitous in the natural environment arising from domestic products as well as current and legacy industrial processes. Many of these organic water pollutants are recalcitrant and only partially degraded using conventional water and wastewater treatment processes. In recent decades, visible light active photocatalyst has gained attention as a non-conventional alternative for the removal of organic pollutants during water treatment, including industrial wastewater and drinking water treatment. This paper reviews the current state of research on the use of visible light active photocatalysts, their modified methods, efficacy, and pilot-scale applications for the degradation of organic pollutants in water supplies and waste streams. Initially, the general mechanism of the visible light active photocatalyst is evaluated, followed by an overview of the major synthesis techniques. Because few of these photocatalysts are commercialized, particular attention was given to summarizing the different types of visible light active photocatalysts developed to the pilot-scale stage for practical application and commercialization. The organic pollutant degradation ability of these visible light active photocatalysts was found to be considerable and in many cases comparable with existing and commercially available advanced oxidation processes. Finally, this review concludes with a summary of current achievements and challenges as well as possible directions for further research. PRACTITIONER POINTS: Visible light active photocatalysis is a promising advanced oxidation process (AOP) for the reduction of organic water pollutants. Various mechanisms of photocatalysis using visible light active materials are identified and discussed. Many recent photocatalysts are synthesized from renewable materials that are more sustainable for applications in the 21st century. Only a small number of pilot-scale applications exist and these are outlined in this review.


Subject(s)
Drinking Water , Water Pollutants, Chemical , Catalysis , Light , Wastewater
7.
MethodsX ; 9: 101706, 2022.
Article in English | MEDLINE | ID: mdl-35518916

ABSTRACT

The ability to identify the origin of phosphorus and understand processes controlling P cycling is essential for designing effective mitigation and restoration of eutrophic freshwater ecosystems. The oxygen isotope composition of orthophosphate (δ18Op) has significant potential as a tracer for P entering freshwater ecosystems. However, methods of analysis of δ18Op are still in their preliminary stages and have proven challenging to implement for new practitioners. In order to achieve progress in developing the application of δ18Op signatures as a tracing tool, there is a need to eliminate the methodological challenges involved in accurately determining δ18Op. This protocol article describes the various steps needed to concentrate and isolate orthophosphate in freshwater samples into an adequately pure Ag3PO4 analyte, without isotopic alteration during processing. The protocol compiles the disperse experiences from previous studies, combined with our own experience. The twofold aim of the paper is toprovide a baseline for an increasing standardisation of the silver phosphate purification method associated with analysis of the oxygen isotope composition of orthophosphate (δ18Op), and to foster new research in the applicability of δ18Op signatures for P source tracing in catchment science.

8.
Thorax ; 66(10): 889-93, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21813622

ABSTRACT

BACKGROUND: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has emerged as an important tool for the diagnosis and staging of lung cancer but its role in the diagnosis of tuberculous intrathoracic lymphadenopathy has not been established. The aim of this study was to describe the diagnostic utility of EBUS-TBNA in patients with intrathoracic lymphadenopathy due to tuberculosis (TB). METHODS: 156 consecutive patients with isolated intrathoracic TB lymphadenitis were studied across four centres over a 2-year period. Only patients with a confirmed diagnosis or unequivocal clinical and radiological response to antituberculous treatment during follow-up for a minimum of 6 months were included. All patients underwent routine clinical assessment and a CT scan prior to EBUS-TBNA. Demographic data, HIV status, pathological findings and microbiological results were recorded. RESULTS: EBUS-TBNA was diagnostic of TB in 146 patients (94%; 95% CI 88% to 97%). Pathological findings were consistent with TB in 134 patients (86%). Microbiological investigations yielded a positive culture of TB in 74 patients (47%) with a median time to positive culture of 16 days (range 3-84) and identified eight drug-resistant cases (5%). Ten patients (6%) did not have a specific diagnosis following EBUS; four underwent mediastinoscopy which confirmed the diagnosis of TB while six responded to empirical antituberculous therapy. There was one complication requiring an inpatient admission. CONCLUSIONS: EBUS-TBNA is a safe and effective first-line investigation in patients with tuberculous intrathoracic lymphadenopathy.


Subject(s)
Biopsy, Fine-Needle/statistics & numerical data , Endosonography/statistics & numerical data , Tuberculosis, Lymph Node/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy, Fine-Needle/methods , Bronchoscopy , Diagnosis, Differential , Endosonography/methods , Female , Follow-Up Studies , Humans , Lymph Nodes/diagnostic imaging , Lymph Nodes/microbiology , Lymph Nodes/pathology , Male , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Reproducibility of Results , Retrospective Studies , Thoracic Cavity , Tuberculosis, Lymph Node/diagnostic imaging , Young Adult
9.
J Environ Qual ; 50(3): 612-626, 2021 May.
Article in English | MEDLINE | ID: mdl-33817794

ABSTRACT

Agriculture is a major source of sediment and particulate phosphorus (P) inputs to freshwaters. Distinguishing between P fractions in sediment can aid in understanding its eutrophication risk. Although streams and rivers are important parts of the P cycle in agricultural catchments, streambed sediment and especially fluvial suspended sediment (FSS) and its P fractions are less studied. To address this knowledge gap, seasonal variations in FSS P fractions and their relation to water quality and streambed sediment were examined in three Swedish agricultural headwater catchments over 2 yr. Sequential fractionation was used to characterize P fractions in both streambed sediment and FSS. All catchments had similar annual P losses (0.4-0.8 kg ha-1 ), suspended solids (124-183 mg L-1 ), and FSS total P concentrations (1.15-1.19 mg g-1 ). However, distribution of P fractions and the dominant P fractions in FSS differed among catchments (p < .05), which was most likely dependent on differences in catchment geology, clay content, external P sources, and flow conditions. The most prominent seasonal pattern in all catchments was found for iron-bound P, with high concentrations during low summer flows and low concentrations during winter high flows. Streambed sediment P fractions were in the same concentration ranges as in FSS, and the distribution of the fractions differed between catchments. This study highlights the need to quantify P fractions, not just total P in FSS, to obtain a more complete understanding of the eutrophication risk posed by agricultural sediment losses.


Subject(s)
Phosphorus , Rivers , Agriculture , Environmental Monitoring , Geologic Sediments , Phosphorus/analysis , Water Movements
10.
Sci Total Environ ; 711: 134616, 2020 Apr 01.
Article in English | MEDLINE | ID: mdl-31812420

ABSTRACT

Excessive phosphorus (P) inputs from agriculture are well established as a contributor to freshwater eutrophication. Decreasing these inputs is an important step in improving the ecological state of impaired waters. Particulate P (PP) is a significant contributor to diffuse P inputs in agricultural catchments. Identifying the main correlates for PP losses is an important step in reducing these inputs. However, there are few studies of long term temporal and spatial dynamics of PP in agricultural streams. Here, we investigate the relative importance of hydrology, catchment characteristics and geochemistry on PP concentrations and fluxes in agricultural headwaters. We evaluate long-term monitoring data from eleven small (<35 km2) Swedish catchments with at least seven years of measured flow and flow proportional water quality sampling. Using parametric and non-parametric regression together with principal components analysis (PCA), we identify in-stream and catchment variables relevant for predicting PP concentrations, e.g., suspended solids concentrations (SS), soil texture and average catchment soil P content, measured as ammonium lactate/acetic acid extractable P (P-AL). We show that PP is primarily correlated to SS concentrations, which in turn are correlated to average clay content and land use. However, the SS:PP relationships differ between catchments. No correlation between PP concentrations in the stream and soil P content was found. An increasing clay content decreases the slope of the relationship between SS and PP, i.e., in catchments with higher clay content, less PP is transported per unit SS. The PP/SS ratio increased significantly (p < 0.05) over time in four catchments, despite limited changes in SS or PP concentrations. Our study highlights the importance of long time series since the enrichment of P on SS in the streams is only detected when using long term monitoring data.

13.
Diabetes ; 51(12): 3412-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12453894

ABSTRACT

The hypothalamic circuits controlling food intake and body weight receive and integrate information from circulating satiety signals such as leptin and insulin and also from ghrelin, the only known circulating hormone that stimulates appetite following systemic injection. Activation of arcuate neurons by ghrelin and ghrelin mimetics (the growth hormone secretagogues) is augmented in 48-h-fasted rats compared with fed rats, as reflected by a greater number of cells expressing Fos protein in response to administration of the same maximally effective dose. Here we sought to determine whether this increased responsiveness in fasting might reflect or be influenced by low levels of circulating satiety factors such as leptin or insulin. Chronic central infusion of insulin or leptin during a 48-h fast suppressed the threefold increase in the Fos response to intravenous injection of a maximally effective dose of growth hormone-releasing peptide (GHRP)-6, a synthetic growth hormone secretagogue. This appears to be a direct central action of insulin and leptin because the marked decrease in plasma levels of insulin, leptin, and glucose during fasting were unaffected by central administration of either hormone. Furthermore, the GHRP-6-induced Fos response was twofold greater in obese leptin- and insulin-resistant Zucker rats compared with lean controls. These data provide evidence that the ghrelin-sensitive circuits in the hypothalamus are dynamically regulated by central insulin and leptin action.


Subject(s)
Arcuate Nucleus of Hypothalamus/physiology , Insulin/pharmacology , Leptin/pharmacology , Oligopeptides/pharmacology , Signal Transduction/drug effects , Signal Transduction/physiology , Animals , Blood Glucose/analysis , Drug Administration Schedule , Fasting/physiology , Injections, Intraventricular , Insulin/adverse effects , Insulin/blood , Leptin/adverse effects , Leptin/blood , Male , Oligopeptides/adverse effects , Osmolar Concentration , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Wistar , Rats, Zucker/metabolism , Reference Values
14.
World J Gastroenterol ; 21(29): 8920-6, 2015 Aug 07.
Article in English | MEDLINE | ID: mdl-26269682

ABSTRACT

AIM: To assess the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and association with drug induced liver injury (DILI) in patients undergoing anti-tuberculosis (TB) therapy. METHODS: Four hundred and twenty nine patients with newly diagnosed TB - either active disease or latent infection - who were due to commence anti-TB therapy between September 2008 and May 2011 were included. These patients were prospectively tested for serological markers of HBV, HCV and human immunodeficiency virus (HIV) infections - hepatitis B core antigen (HBcAg), hepatitis B surface antigen (HBsAg), hepatitis B e antigen, IgG and IgM antibody to HBcAg (anti-HBc), HCV IgG antibody and HIV antibody using a combination of enzyme-linked immunosorbent assay, Western blot assay and polymerase chain reaction techniques. Patients were reviewed at least monthly during the TB treatment initiation phase. Liver function tests were measured prior to commencement of anti-TB therapy and 2-4 wk later. Liver function tests were also performed at any time the patient had significant nausea, vomiting, rash, or felt non-specifically unwell. Fisher's exact test was used to measure significance in comparisons of proportions between groups. A P value of less than 0.05 was considered statistically significant. RESULTS: Of the 429 patients, 270 (62.9%) had active TB disease and 159 (37.1%) had latent TB infection. 61 (14.2%) patients had isolated anti-HBc positivity, 11 (2.6%) were also HBsAg positive and 7 (1.6%) were HCV-antibody positive. 16/270 patients with active TB disease compared to 2/159 patients with latent TB infection had markers of chronic viral hepatitis (HBsAg or HCV antibody positive; P = 0.023). Similarly the proportion of HBsAg positive patients were significantly greater in the active vs latent TB infection group (10/43 vs 1/29, P = 0.04). The prevalence of chronic HBV or HCV was significantly higher than the estimated United Kingdom prevalence of 0.3% for each. We found no association between DILI and presence of serological markers of HBV or HCV. Three (5.3%) patients with serological markers of HBV or HCV infection had DILI compared to 25 (9.5%) patients without; P = 0.04. CONCLUSION: Viral hepatitis screening should be considered in TB patients. DILI risk was not increased in patients with HBV/HCV.


Subject(s)
Coinfection , Hepatitis B/epidemiology , Hepatitis C/epidemiology , Latent Tuberculosis/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Antitubercular Agents/adverse effects , Biomarkers/blood , Chemical and Drug Induced Liver Injury/diagnosis , Chemical and Drug Induced Liver Injury/epidemiology , Female , Hepatitis B/diagnosis , Hepatitis C/diagnosis , Humans , Latent Tuberculosis/diagnosis , Latent Tuberculosis/drug therapy , Liver Function Tests , Male , Mass Screening , Middle Aged , Predictive Value of Tests , Prevalence , Prospective Studies , Risk Assessment , Risk Factors , Time Factors , Treatment Outcome , United Kingdom/epidemiology , Young Adult
15.
Pediatr Infect Dis J ; 33(12): 1303-6, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25105895

ABSTRACT

Risk factors associated with Mycobacterium tuberculosis infection were investigated in a prospective cohort of household child tuberculosis contacts. A significantly increased risk of acquiring infection was associated with exposure to passive cigarette smoke, higher number of index cases, younger age and reduced household monthly income.


Subject(s)
Family Characteristics , Family Health , Tobacco Smoke Pollution/adverse effects , Tuberculosis, Pulmonary/epidemiology , Adolescent , Age Factors , Child , Child, Preschool , Cohort Studies , Female , Humans , Infant , Male , Mycobacterium tuberculosis/isolation & purification , Prospective Studies , Risk Assessment , Socioeconomic Factors
16.
Ann Am Thorac Soc ; 11(3): 392-6, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24592937

ABSTRACT

RATIONALE: The Xpert (GeneXpert) MTB/RIF, an integrated polymerase chain reaction assay, has not been systematically studied in extrapulmonary and in particular mediastinal tuberculosis (TB). OBJECTIVES: To investigate the performance of Xpert MTB/RIF in the diagnosis of intrathoracic nodal TB in a large tertiary urban medical center in the UK. METHODS: We collected clinical, cytological, and microbiological data from two cohorts: 116 consecutive patients referred with mediastinal lymphadenopathy with detailed diagnostic information obtained, and an immediately subsequent second cohort of 52 consecutive patients with microbiologically confirmed mediastinal TB lymphadenopathy. All data were derived between January 2010 and October 2012. All patients underwent endobronchial ultrasound and transbronchial needle aspiration (TBNA). The performance of a single Xpert MTB/RIF assay alongside standard investigations, cytology, and microscopy/culture was evaluated against culture-confirmed TB. MEASUREMENTS AND MAIN RESULTS: Microbiologically confirmed TB mediastinal lymphadenopathy was diagnosed in a total of 88 patients from both cohorts. Three culture-negative cases with associated caseating granulomatous inflammation on TBNA were given a probable diagnosis. A single Xpert MTB/RIF assay demonstrated overall sensitivity for culture-positive TB of 72.6% (62.3-81.0%). Xpert specificity from cohort 1 was 96.3% (89.1-99.1%). The positive predictive value was 88.9% (69.7-97.1%), negative predictive value was 86.5% (76.9-92.1%), and odds ratio was 51.3 (24.0-98.0) for correctly identifying culture-positive disease. Xpert captured all microscopy-positive cases (14 of 14) and the majority of microscopy-negative cases (48 of 71, 67.6%). Among the cases that were culture positive by TBNA, Xpert identified two-thirds of the multiple drug-resistant TB cases, leading to immediate regimen change up to 5 weeks ahead of positive cultures. The use of Xpert combined with cytology increased the sensitivity to 96.6%. CONCLUSIONS: Xpert MTB/RIF provides a rapid, useful, and accurate test to diagnose mediastinal nodal TB in intermediate-incidence settings. The additional use of TBNA cytology further enhances the sensitivity of Xpert. This combination can facilitate rapid risk assessment and prompt TB treatment.


Subject(s)
Lymphatic Diseases/microbiology , Mediastinal Diseases/microbiology , Mycobacterium tuberculosis/isolation & purification , Polymerase Chain Reaction , Rifampin , Tuberculosis, Multidrug-Resistant/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Antibiotics, Antitubercular , Bronchoscopy , Cohort Studies , Drug Resistance, Bacterial , Endoscopic Ultrasound-Guided Fine Needle Aspiration , Female , Humans , Lymphatic Diseases/diagnosis , Male , Mediastinal Diseases/diagnosis , Middle Aged , Sensitivity and Specificity , Young Adult
18.
Respir Med ; 105(11): 1726-31, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21840695

ABSTRACT

INTRODUCTION: Patients with suspected active Pulmonary Tuberculosis (PTB) who are Acid-Fast Bacilli (AFB) smear negative or non-productive of sputum may undergo bronchoalveolar lavage. However, post-bronchoscopy sputum (PBS) sampling is not routine. The aim of this study was to establish the potential diagnostic value of PBS sampling. METHODS: A retrospective study of patients attending a London University hospital with microbiologically confirmed PTB between January 2004 and December 2010. Patients who were AFB smear negative or non-productive of sputum were eligible if sputum sampling was performed within 7 days of bronchoscopy. RESULTS: Over the study period, 236 patients had microbiologically confirmed smear negative PTB of which 57 patients were eligible for the study. 15 patients (26.3%) were infected with HIV. 19 patients (33.3%) converted to AFB sputum smear positivity post-bronchoscopy and 5 patients (8.8%) were exclusively AFB sputum smear positive on PBS microscopy. Mycobacterium tuberculosis was cultured from the PBS of 43 patients (75.4%) and of these, 4 (7.0%) were exclusively PBS culture positive. CONCLUSION: PBS analysis can provide a simple method of rapidly diagnosing pulmonary tuberculosis. In this cohort, M. tuberculosis culture yield was increased by 7% through PBS sampling. This study has important infection control implications with nearly one third of patients becoming more infectious after bronchoscopy.


Subject(s)
Bronchoalveolar Lavage Fluid/microbiology , Bronchoscopy , Mycobacterium tuberculosis/isolation & purification , Sputum/microbiology , Tuberculosis, Pulmonary/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , London/epidemiology , Male , Middle Aged , Retrospective Studies , Sensitivity and Specificity , Tuberculosis, Pulmonary/epidemiology , Tuberculosis, Pulmonary/physiopathology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL